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ABSTRACT 
In this paper, we look at how the early detection of health decline 
in those with Chronic Obstructive Pulmonary Disease can lead to 
earlier provision of intervention advice. Current tools to support 
the self-management of Chronic Obstructive Pulmonary Disease 
provide alerts only when a problem has been encountered. It is 
suggested that continuous monitoring of a user’s health, behavior 
and contextual information when appropriate would provide the 
ability to detect health decline prior to a problem having occurred. 
Based on the review of the current body of work, important 
parameters for self-management have been identified; autonomy, 
methods of data transmission, and levels of intrusiveness. An 
autonomous context aware self-management tool is subsequently 
proposed. The approach aims to incorporate recent advances in 
mobile technology and overcome many of the limitations 
encountered in the solutions considered to date. 
Categories and Subject Descriptors 
D.3.3 [Computer Applications]: Life and medical sciences– 
Medical information systems 
General Terms 
Algorithms, Measurement, Documentation, Performance, Design, 
Reliability, Experimentation, Human Factors, Standardization. 
Keywords 
Chronic Obstructive Pulmonary Disease, Self-Management, Tele-
Monitoring. 
1. INTRODUCTION 
A dramatic shift in population ageing is currently taking place. 
The global median age has been projected to increase from 37.3 
years in 2000 to 47.7 years in 2050 [1]. This shift will have a 
profound impact in a number of areas, one such area being 
healthcare. Increased life expectancy raises the number of people 
at risk of developing chronic conditions which are more prevalent 
in older age groups [2]. This subsequently leads to an increased 
demand for healthcare provision and results in spiraling medical 
costs [3]. Self-management solutions realized through a 
technological infrastructure may be a means to alleviate this 
burden. In addition, it provides an opportunity to empower the 
patient with an increased level of control over their own 
healthcare [4].   
By 2030 the World Health Organization (WHO) has predicted 
that Chronic Obstructive Pulmonary Disease (COPD) will affect 
over 64 million people and will be the third leading cause of death 
worldwide [5]. It is estimated that over 3 million people are 
currently affected by COPD in the UK with only 900,000 having 
been clinically diagnosed [6]. 
The economic impact of COPD is significant with respiratory 
disease consuming 6% of the European Union healthcare budget 
[7]. COPD accounts for over 50% of this cost totaling over 38.6 
billion Euro [7]. As would be expected, costs associated with 
COPD dramatically increase as disease progression occurs. 
Economic hardship can also be found in those with COPD as they 
or their partner may no longer be able to work as the burden of 
care takes its toll [7][8]. Social burden can also be found in those 
with COPD when analyzing the total number of lost Disability 
Adjusted Life Years (DALY) [9]. In addition, COPD was ranked 
as the 11th leading cause of lost DALY in 2002 and has been 
predicted to be the 7th leading cause of lost DALY worldwide by 
2030 [10]. 
There are a number of key indicators of COPD such as dyspnea, 
chronic cough and sputum production, however, the use of 
spirometry measurements is the only consistent and reliable 
method of detecting airflow obstruction.  As such spirometry 
measurement is a prerequisite for a COPD diagnosis and in the 
determination of COPD severity (Table 1) [11]. It is important 
that each person is accurately assessed as this correlates directly 
with morbidity and mortality [12], however, it is interesting to 
 
note that a poor severity rating does not necessarily correlate 
directly to a poor health related quality of life (HRQoL) [13] [14].  
Table 1 Classification of severity of airflow limitation in 
COPD from the Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) [15] 
Severity Forced Expiratory Volume (FEV) Reading 
Mild FEV ≥ 80% predicted 
Moderate 50% ≤ FEV < 80% predicted 
Severe 30% ≤ FEV < 50% predicted 
Very severe FEV < 30% predicted 
 
Exacerbations are a common feature of COPD and are associated 
with an increase in symptoms such as nocturnal awakening, 
breathlessness and chronic cough or wheeze alongside a marked 
change in sputum production [16]. It has been asserted that early 
exacerbation treatment improves HRQoL and ensures timely 
recovery [17]. Delayed seeking of treatment, however, was noted 
to lower HRQoL, delay recovery time substantially and 
dramatically increase hospitalization risk [18]. Early detection of 
an oncoming exacerbation, together with appropriate intervention 
leads to the reduction in the severity of the exacerbation itself and 
the slowing of disease progression [18]. It has also been shown 
that pharmacologic therapies, pulmonary rehabilitation and 
smoking cessation all deliver significant benefit to people with 
COPD, however adherence and compliance with intervention and 
self-management techniques is poor [19] [20]. It is suggested in 
this paper that further research on improving patient adherence to 
therapy through the use of emerging mobile technology may 
result in fewer hospitalisations due to preventable COPD 
complications. 
A number of research projects have focused on the area of user 
monitoring and alert generation when a health problem has been 
detected in those with COPD [21][22]. Alerting when a problem 
has occurred is limited in its benefit, as a difficulty has already 
been encountered. It is therefore proposed that an unobtrusive 
system, monitoring a user's health, behavior and environment for 
undesirable changes can lead to the provision of timely advice, 
therefore enabling the user to change their lifestyle and prevent a 
problem from occurring.  This notion of moving from reactive to a 
proactive monitoring situation is in line with many recent 
developments in the area of technology based solutions in support 
of long term chronic conditions. 
The remainder of this paper is structured as follows. Section 2 
provides a review of related work in the area of mobile self-
management for COPD. Section 3 details identified areas for 
improvement and Section 4 presents the details of a proposed 
system taking into consideration the current challenges in this 
domain. Section 5 provides a summary. 
2. RELATED WORK 
Self-management in the context of COPD involves the provision 
of feedback of symptoms and educational content, enabling one, 
to take control and manage symptoms, medication and lifestyle 
choices so that HRQoL may be increased and the chronic 
condition controlled [23]. Self-management has proven to be 
effective in the management and control of COPD in a number of 
studies with intervention groups showing distinctly lower 
hospitalisation or emergency room visits than control groups. A 
systematic Cochrane review of 14 randomised trials from (January 
1985 to January 2006) found that self-management was associated 
with lower hospitalisations alongside an improvement in health 
related quality of life for those with COPD [24]. Mobile device 
use in the self-management of COPD is a new approach with 
more work needed in this area [25].  
A review was carried out to determine the state of the art 
techniques for the self-management of COPD. Google Scholar, 
PubMed and IEEE databases were searched utilizing a number of 
key terms (Table 2) whilst limiting the search to only papers 
written in English and published between 2010 to 2013.   
Table 2 Key search terms used when reviewing of related 
work 
Search Terms  
"Chronic Obstructive Pulmonary Disease" OR “COPD” AND 
"Self-management" AND “Mobile” 
"Chronic Obstructive Pulmonary Disease" OR “COPD” AND 
“mobile” 
"Chronic Obstructive Pulmonary Disease" OR “COPD” AND 
"Self-management" AND “mhealth” 
"Chronic Obstructive Pulmonary Disease" OR “COPD” AND 
"Self-management" AND “smart phone” 
"Chronic Obstructive Pulmonary Disease" OR “COPD” AND 
“smart phone” 
 
Google Scholar returned 2151 papers, PubMed / Medline returned 
309 papers and IEEE returned 115 papers in total. From this 
group, the papers were further refined by title and abstract and 25 
papers subsequently reviewed in full. From this seven key papers 
in the area where selected for more detailed consideration. 
From the review it was apparent that tele-monitoring can be 
divided into two categories:(1) data is communicated to a 
clinician who decides upon a relevant course of action [26] [27] 
and (2) systems with intelligence that perform some aspect of data 
analysis autonomously, thus reducing the need for a clinician and 
providing timely advice and alerts to the patient [28] [29].  
2.1 Non-Automated Systems 
The review carried out yielded two projects that communicated 
information directly to the clinician for further analysis. ASTRI 
(ATS) [26] was created to investigate user acceptance of a tele-
care system. Twenty-two people were included in the intervention 
group for this project alongside 18 controls. Sensors measuring 
respiratory rate, pulse and blood oxygen levels [26] were 
connected wirelessly through to a mobile device and from there to 
an online personal health database. Monitoring of the 
physiological parameters took place three times a day, Monday 
through to Friday by the community nurse who would take 
relevant action if it was determined that the user was in danger. It 
was noted that monitoring of recorded data was not supported 
over weekends or bank holidays [26]. User feedback indicated 
satisfaction with the system, however, it was stated that the 
addition of automated advice on healthcare would have been of 
benefit. 
A second non-automated system AMICA [27] was developed to 
enable the early detection of an oncoming exacerbation. The 
system utilized a holistic approach to the management of COPD. 
AMICA recorded a number of physiological signals from each 
user including sound and ECG via a custom multifunctional 
sensor. Recorded sound and ECG signals had a number of 
biomarkers extracted prior to being uploaded to a remote 
electronic patient record via a mobile device [27]. The mobile 
device within this project served a number of functions, including 
the provision of educational content and also the completion of an 
emulated medical consultation. The emulated medical 
consultation was a key part of this project and can be viewed as 
being a novel method for extracting data on the user's wellbeing. 
Nevertheless, similar to ASTRI, information recorded was 
subsequently transmitted to a clinician for further analysis, 
therefore delaying the time in which feedback was provided. 
2.2 Automated Systems 
A number of systems were encountered that autonomously carried 
out data analysis for mobile self-management of COPD. The 
projects encountered varied in their objectives, ranging from the 
long term monitoring of COPD, exacerbation prediction and 
evaluating the impact that tele-monitoring had on hospital 
admission.  
2.2.1 Long Term Monitoring 
Four systems were reported in the area of long term monitoring. 
Chronious [30] was a partially automated system consisting of 
multiple “unobtrusive wearable sensors” allowing physiological 
parameters such as heart rate, respiration rate and accelerometer 
data to be monitored over long periods of time. The system also 
utilized numerous wireless sensors placed within the home 
environment recording data on ambient light levels, carbon 
monoxide levels and volatile organic compounds [30].  All 
recorded data was transmitted wirelessly back to a handheld 
personal digital assistant (PDA) which could be used to manually 
input information on lifestyle and food intake [30].  
Recorded data were analysed autonomously on the PDA and an 
alert issued directly to the clinician on detection of a problem. The 
system provides the clinician with possible courses of action to 
take, generated through automated analysis of historical data. 
Chronious aimed to “infer complex information about the user's 
actions, the situation around them, and their interactions with the 
environment” [30] whilst also aiding clinicians in the management 
of their patients on a day-to-day basis. The aim was to reduce 
condition decline and prevent further exacerbations.  
M-COPD [31] was developed to enhance communication between 
patients and clinicians, whilst also providing clinicians with the 
ability to monitor their patients remotely. This project aimed to 
help identify oncoming exacerbations and subsequently aid in the 
treatment of exacerbations with medication [31]. Users within this 
study were provided with a pulse oximeter and thermometer 
enabling them to record vital sign data; a mobile phone enabling 
the manual entry of recorded data alongside observational data on 
their condition [31]. Once input, the mobile phone transmits the 
recorded data directly to the hospital, where it is automatically 
analysed and an easy to understand graphical representation of the 
data is provided to the clinician. Clinicians subsequently 
determine if educational or intervention information should be 
provided [31].  
It was indicated that the integration of rule based alerting 
mechanisms similar to the Chronious system [30] could be added 
to M-COPD. This would enable automatic alerts to be sent 
through to clinicians if vital signs were to go outside predefined 
ranges. This rule based mechanism has not yet, however, been 
implemented [31]. It is interesting to note that similar to 
Chronious, the user was not provided with any feedback on their 
condition; all information was passed back to the clinician.  
A further study [28] had the aim of understanding how tele-
monitoring interventions backed by primary care impact upon 
recurring hospital admissions for those with COPD. The basis for 
this project was founded on the understanding that early 
exacerbation detection profoundly affects health related quality of 
life while also reducing the cost on the health system [18]. To 
determine the effect that tele-monitoring had, an intervention 
group recorded vital signs daily using a tele-monitoring kit 
provided while also completing a mobile-based questionnaire on 
perceived levels of health.  
Recorded data was uploaded daily and reviewed by a health 
professional, the participant had direct contact with a clinical 
professional on a bi-weekly basis [28] and personalized alerts 
were triggered if recordings were found to be outside of a pre-
defined  range (Table 3). 
Table 3 Pre-defined ranges at which an alert would be issued 
if reached [28] 
Tele-monitored 
parameters 
Established threshold values 
Respiratory-rate < 12 or > 24 breath per minutes 
(bpm) 
Heart-rate < 50 or > 100 beats per minute 
(bpm) 
Systolic blood pressure <100 or > 160 millimetres of 
mercury (mmHg) 
Oxygen saturation < 95% (this is a frequently adjusted 
limit for patients with chronic lung 
disease) 
Temperature > 37°C 
Weight Should be notified if there is an 
increase of 1 kg in three days 
Qualitative 
questionnaire 
Negative answer to the 
questionnaire which correspond to: 
feeling worse, breathing 
difficulties, increased nocturnal, 
oedema, worsening of cough, 
increased sputum production and a 
change in sputum colour 
 
The eCAALYX Project aimed to monitor user's health status by 
recording vital signs over a longitudinal period of time to detect 
changes in their condition and subsequently the progression of 
COPD. Similar to Chronious an educational module providing 
participants with general information on self-management and 
lifestyle changes to adopt was provided [29]. The eCAALYX 
system utilizes two individual methods of monitoring: a mobile 
body worn system alongside a home based system comprising of 
multiple sensors integrated into the user's environment.  
Unique to eCALLYX a smart garment embedded with multiple 
sensors was used for the mobile monitoring system with 
physiological data such as respiration and skin temperature 
recorded [29]. The home-based monitoring system was integrated 
with the user's TV providing a platform for viewing recorded vital 
signs and historical recorded data [29]. The set top box connected 
to the TV also enabled input of questionnaire data alongside the 
provision of educational content and teleconference calls to the 
clinician when necessary [29]. eCAALYX is unique compared to 
other reviewed systems [28] [29] as it is the first system to 
provide direct feedback to the end user. Feedback of this nature 
may be empowering for the participant therefore encouraging life 
style change compliance and aiding in motivation. Feedback from 
participants, however, was not positive. Nine volunteers evaluated 
the system for a total of 28 days and found aspects of the system 
“difficult to use” and garments to be “uncomfortable”. 
2.2.2 Full Automation 
One autonomous system [32] is currently under development 
aiming to provide computer aided self-management assistance and 
education while also enabling the detection of an oncoming 
exacerbation. The system aims to ensure that any event changes 
are detected, relevant people alerted and the condition monitored.   
 
The main computational component within this system is a smart 
mobile device [32]. The mobile device is powerful enough to 
carry out all processing and communication required and removes 
the need for a dedicated computer system, thus reducing 
unnecessary technology and ensuring the system is unobtrusive 
unlike eCALLYX. A number of sensors are used to record vital 
sign information similar to each of the other projects evaluated 
and similarly a questionnaire on the mobile device is used to 
record relevant information related to the user's health [32]. What 
makes this system unique, however, is the integration of a 
“disease-specific probabilistic model”. This Bayesian network 
was developed from expert knowledge[32]. An initial evaluation 
of the system was completed successfully with 5 participants from 
a lung rehabilitation program [32]. It was established that an 
exacerbation could in fact be detected autonomously ‘as it was 
occurring’,  using the probabilistic model on the mobile device. 
This is a step forward in the development of autonomous self-
management devices and paves the way for future work in this 
area. Researchers intend to work on earlier detection of an 
oncoming exacerbation and subsequently offer relevant advice to 
patients helping them better self-manage their condition [32].  
 
Table 4 provides an overview on physiological data recorded in 
the projects reviewed. Table 5 presents a comparison between 
projects reviewed and the proposed COPD self-management 
system presented in this paper. 
2.3 Future Developments 
The Smart 3 Holistic Self-Management [33] project aims to create 
a self-management system for those with COPD,  however,  the 
proposed approach will identify how technology can be best 
utilized for self-management and rehabilitation. Smart 3 will be 
built upon a previously successful project entitled Smart 2 [34]. 
Smart 2 successfully utilized technology, intervention and 
educational information to support users with long term chronic 
conditions such as chronic heart failure and stroke achieve 
behavioral and lifestyle changes. Smart 3 builds on this project 
ensuring those with COPD self-manage their condition through a 
combination of personal and intervention advice on holistic self-
management techniques. This aims to ensure a better quality of 
life for each individual user 
 
Table 4 Key papers in the area of mobile self-management detailing the physiological data recorded. 
Paper Ref SP02 Pulse ECG FEV Respiration Temperature Blood Pressure Weight 
[26] ✔ ✔ ✖ ✖ ✔ ✖ ✖ ✖ 
[27] ✔ ✔ ✔ ✖ ✖ ✖ ✖ ✖ 
[28] ✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ 
[29] ✔ ✔ ✖ ✖ ✖ ✔ ✖ ✖ 
[29] ✔ ✔ ✔ ✖ ✔ ✔ ✔ ✔ 
[28] ✔ ✔ ✖ ✖ ✔ ✔ ✔ ✔ 
[32] ✔ ✔ ✖ ✔ ✖ ✖ ✖ ✔ 
 
Table 5 Assessment criteria comparison between reviewed and proposed COPD self-management systems 
Paper Ref SP02 Pulse Respiration Activity Location Sleep Environment 
Data ( Weather) 
Diet 
[26] ✔ ✔ ✔ ✖ ✖ ✖ ✖ ✖ 
[27] ✔ ✔ ✖ ✔ ✖ ✖ ✖ ✖ 
[28] ✔ ✔ ✔ ✔ ✖ ✔ ✔ ✔ 
[29] ✔ ✔ ✖ ✖ ✖ ✖ ✖ ✖ 
[29] ✔ ✔ ✔ ✔ ✖ ✖ ✖ ✖ 
[28] ✔ ✔ ✔ ✖ ✖ ✖ ✖ ✔ 
[32] ✔ ✔ ✖ ✖ ✖ ✖ ✖ ✖ 
Proposed 
System 
✔ ✔ ✔ ✔ ✔ ✔ ✔ ✔ 
 
 
 
3. LIMITATIONS ENCOUNTERED 
While reviewing the related work, a number of limitations were 
encountered. These can be overcome and a more comprehensive 
system developed that will improve upon current mobile based 
self-management systems for COPD. 
3.1 Autonomy 
The projects reviewed do not have a set methodology for 
providing the end user with feedback on the vital sign readings, it 
was found these readings were sent to the clinician who would 
then review and if necessary offer intervention information. This 
is a missed opportunity to help end users self-manage their 
condition effectively. Providing end users with feedback on 
recorded data may provide them with a better understanding of 
their condition thus providing the necessary incentive required to 
manage their lifestyle accordingly. A number of systems reviewed 
only supported the transmission of intervention information and 
the display of self-management and motivational information 
when the clinician determined it necessary. An autonomous 
system that assessed recorded biomarkers against a number of 
pre-set guidelines may provide a superior system that could 
subsequently cut down on the clinician’s workload. 
Similarly, community nurses involved in the review of transmitted 
data in systems such as [26] have indicated that they would 
welcome easy to read reports and charts detailing recorded vital 
signs as it is difficult and time consuming to review raw data. The 
generation of this information would alleviate such problems. It is 
also reasonable to assume that historical data in a graphical form 
would be of interest and benefit to the end-user.  
Furthermore, it was noted that certain projects relied on clinical 
professionals to monitor data on a daily basis, determining if vital 
signs were within the pre-set safe ranges.  Participants involved in 
[26] were unable to receive tele-care at the weekend or on bank 
holidays as the community nurse was unavailable, further 
demonstrating the need for an automated system. 
One of the benefits of mobile health is the processing capability 
such devices contain, carrying out automation and subsequently 
reducing clinician workload [32]. If data analysis was to be 
carried out on the mobile device, the end user could be provided 
with immediate feedback on their condition. 
3.2 Data Transmission 
It was observed in [27] that transmission of data occurred via a 
device located at the patient’s home. It can be assumed that 
transmission of monitoring data cannot take place if the user is not 
in the home. This restriction may impact on the duration of time 
the participant can be away from their home, thus limiting their 
movement. Alternatively users would forego the transmission of 
physiological data that would have taken place had they been at 
home. 
A secondary limitation encountered regards the transmission 
methods used for the transfer of recorded data. GPRS is utilized 
for data transmission in [28]. Utilising cellular transmission of 
data ensures the user is no longer restricted to staying in the 
house, however, if the user was to be in a rural area with limited 
network signal, it may still be difficult or impossible to transmit 
recorded data and receive relevant self-management or essential 
intervention techniques consistently. 
In [29] a separate issue was encountered concerning the upload of 
data from the home unit. For this particular project, data uploads 
took on average 3.5 hours. Clearly this is unacceptable for the 
transmission of vital sign data, particularly if that data was to 
reveal a serious problem oncoming or having occurred. 
3.3 Intrusiveness 
It was established that certain systems over complicate the process 
of managing COPD to the degree that it may be off-putting to 
potential participants. Tele-care should be unobtrusive with 
technology deployed discretely within the environment. For 
instance, questionnaire information can be accomplished through 
a smart mobile device. The technology employed for management 
of chronic conditions such as COPD should be directed to the 
background[35]. 
On the contrary, participants in [26] had requested that the 
addition of a blood pressure monitor would be of benefit. This 
project, however, contained minimal technology in comparison to 
[29]. A compromise somewhere between these projects may 
provide the best solution.  
It is also suggested that much of the manual data entry completed 
by the end users may not be necessary. The use of sensors to take 
readings and then request users to manually enter the results may 
lead to discrepancies. It is also conceivable that users may under 
report problems so as to not cause unnecessary concern to others. 
The use of sensors that automatically transmit data would remove 
such an issue.  
3.4 Technology 
Many of the projects reviewed utilized PDA devices as the mobile 
technology to be provided to the end user. Modern Smart phone 
devices contain many onboard sensors making the phone more 
than just a means of providing data. Onboard sensors such as  
GPS, gyroscope, accelerometers, and light sensors, enable the 
mobile device to play a larger role in the data collection process. 
Application programming interfaces (APIs) are available that 
allow the direct connection and analysis of external sensors 
through to the mobile device. It is proposed that the use of a 
modern smart phone device enables a more adaptable system to be 
developed that is no longer as restricted as was previously the 
case with PDAs. 
3.5 Parameters for COPD Self-management 
A number of limitations were encountered while reviewing the 
current body of work contributing to the area of self-management 
for those with COPD.  It was found that each research project had 
a number of properties that were of benefit to the end user. Each 
project however, also had aspects that could have been improved 
upon. It is hypothesized that the creation of a system merging 
many of the beneficial properties while removing the poorer 
aspects of the projects would be of benefit. Future projects should 
take into account the following: 
Autonomy; enabling intervention and self-management advice to 
be provided to the end user, removing the need for a clinician to 
evaluate data regularly. This will also allow for users to have 
educational or self-management information provided to them at 
optimal times. 
Improved data transmission allowing data to be updated over 
3G/4G or Wi-Fi should be implemented. Users should not be 
restricted in this regard. If no transmission method is available, 
data should be buffered until such a time that it is available. 
Finally, solutions should be discreet and unobtrusive. Solutions 
should not overwhelm or intimidate the end user but still provide 
a comprehensive health overview. 
4. PROPOSED SOLUTION 
The proposed solution is a mobile-based self-management tool 
that will allow the unobtrusive monitoring of a user’s health 
condition over a prolonged period of time. The system will enable 
the detection of minor changes in health condition, thus allowing 
for intervention or educational material to be provided when 
required autonomously. It is proposed that these detections could 
lead to earlier non-pharmaceutical interventions leading to a 
reduction in disease progression and complications in those 
suffering from COPD. Figure 1 provides an overview of the 
proposed self-management approach. 
 
Figure 1 The System architecture of the proposed self-
management tool, with each element defined  
The system architecture depicted in Figure 1 can be broken into a 
number of key areas that help to clarify how the system operates. 
All physiological, environmental or user inputted data (Figure 3) 
will initially pass through the context awareness/tele monitoring 
module. All data will be stored in a local database. Following this, 
a process will take place to determine if the user is currently in a  
state of health decline; to determine this, a number of algorithms 
will evaluate the recorded data. If it is determined the user is not 
in decline, no further action will be taken, and the data collection 
will continue. If the user is however deemed to be in decline, pre-
defined rules based on recorded vital signs will determine if 
immediate medical help is required or not. If required, a clinician 
will be alerted and an ambulance requested if necessary. If clinical 
help is not required, a prediction model will establish the best 
intervention advice to be provided. The system will then continue 
to monitor the user and evaluate health for improvement or 
decline. 
4.1 Visual Interface Module 
The visual interface offered to the user should be  appealing, and 
intuitive. The interface will provide the user with feedback on 
recorded data and symptoms in addition to offering educational 
material and intervention advice. The feedback will be provided at 
the user’s request and also as and when necessary. Proposed 
screens are shown in Figure 2. It is imperative that recorded data 
is not overwhelming while providing the user with an overview of 
their health status, clearly showing improvement or decline. It is 
asserted that this visual representation may potentially encourage 
behavioral change. 
 
 
Figure 2 Initial screens showing how data may be presented to 
the end user 
4.2 Context Aware / Tele-Monitoring Module 
This module ensures that data relevant to a user's health condition 
is monitored and recorded thus generating a dataset for 
assessment and providing information relevant for helpful advice 
to be provided. For example, information on environmental 
factors such as air pollution, which has been directly linked to 
increased hospital admissions for those with COPD [36] can be 
harvested from online weather sources directly. Mobile 
accelerometers combined with GPS data will be used to determine 
user location and subsequent activity levels or in some cases, lack 
of activity.  It is conceivable that a combination of environmental, 
location and accelerometer data could determine that the user is 
exercising in an area with poor air quality that should be avoided. 
This module will also monitor diet, sleep and vital sign data 
through a combination of body worn and wireless sensor devices 
and when necessary user inputted information.  
 
Figure 3 Depicting data that will be recorded in the Context 
aware / tele-monitoring module 
All data monitored through the context aware tele-monitoring 
module will be stored in an SQLite database on the mobile device. 
This database will store raw data recorded and associated 
timestamps. 
4.3 Health Evaluation Module (Healthy or 
Not Healthy) 
The health evaluation model comprises a number of rules that 
determine if the data recorded implies that the user is either 
healthy or unhealthy. These rules will be based on preset ranges 
specific to each individual user. If vital signs are within preset 
safe ranges, the monitoring process will continue uninterrupted. If 
the user is deemed to be unhealthy based on the data analyzed, 
one of two outcomes will occur. If the user is deemed to be 
dangerously unhealthy, a clinician will be contacted and an 
ambulance requested if necessary, if, however, it is determined 
that the user is not in danger or in need of clinical assistance the 
probabilistic module will then be initiated. 
4.4 Prediction Module 
A prediction model will be employed to determine appropriate 
intervention advice to be provided to the user if their health is 
found to be declining. Clinical experts working in the area of 
COPD self-management will have validated the intervention 
advice to be provided. An example use case for this module could 
be for a user lacking exercise alongside increased levels of 
fatigue. The module would analyze all recorded data and 
determine that user had not been consuming enough calories, as 
such, intervention advice encouraging a higher calorie intake 
would be offered. It is proposed that this intake might then 
provide the required energy to reduce fatigue levels and therefore 
motivate the user to exercise. It is conceivable, in such a scenario 
that recommendations on diet plans specific to that user could be 
offered. 
If it is deemed necessary, following intervention advice being 
provided, detailed information specifying the initial health decline 
encountered and the subsequently prescribed intervention 
information could be securely transmitted through to a clinician. 
It is proposed that the creation of an automated self-management 
tool, providing relevant and timely intervention advice alongside 
self-management and educational information to the end user. The 
suggested system should be enjoyable to use, therefore 
encouraging behavioral change in a novel manner. At present no 
research has been found relating to the provision of a mobile 
smart device as a tool providing a significant health overview 
whist also detecting subtle changes in health so that an oncoming 
setback can be prevented. It is also conceivable that such a system 
may be of use in determining how medication changes affect the 
health of a patient.  
5. CONCLUSION 
This paper provides an assessment of mobile self-management 
solutions for those with COPD. It was found that while significant 
work has previously been carried out, there is still room for 
improvement, specifically with regard to patient empowerment, 
monitoring of health and providing relevant contexual, 
educational and management information. It is proposed that the 
development of an unobtrusive self-management platform aimed 
at overcoming limitations in the autonomous nature of mobile 
systems alongside improvements in the transmission of necessary 
data and ensuring systems are intuitive to use will bring with it 
great benefits for those with COPD.  
Development of this system is currently ongoing and will be 
evaluated by a cohort of users with COPD. Presently, no dataset 
has been found that provides all data required to develop and 
evaluate such an approach. Therefore, the creation of a symptom 
emulator will also take place. Initial development of the COPD 
symptom generator has commenced with the platform currently 
enabling users to generate COPD symptoms ranging from mild, 
moderate and severe. 
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